Funds · 13F holdings

Eleva Capital SAS

13F holdings for Q2 2026 · PARIS, I0 · filed July 2, 2026

Eleva Capital SAS reported $344M in 13F securities across 24 holdings for Q2 2026, in a Form 13F filed July 2, 2026. The largest positions were CRH PLC Ord (81.1%), Amer Sports Inc (2.9%), NVDA (2.6%). Reported value rose 0.0% from the quarter before.

13F value Q2 2026
$344M
Holdings
24
Change vs prior quarter
+0.0%
Rank by 13F value
#4,864

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Top holdings

StockValueWeightSharesChange in sharesMove
CRH PLC Ord$279M81.1%2,654,9740%Unchanged
Amer Sports Inc$9.8M2.9%298,8020%Unchanged
NVDA NVIDIA Corporation$9.1M2.6%52,0020%Unchanged
NFLX Netflix Inc.$8.4M2.4%87,1900%Unchanged
GOOGL Alphabet Inc.$8.0M2.3%27,9670%Unchanged
TSM Taiwan Semiconductor Manufacturing Company Ltd.$6.5M1.9%21,4110%Unchanged
ANET Arista Networks Inc.$5.8M1.7%46,9570%Unchanged
AMZN Amazon.com Inc.$3.4M1.0%16,1550%Unchanged
TMUS T-Mobile US Inc.$3.0M0.9%14,3470%Unchanged
HOOD Robinhood Markets Inc.$2.2M0.6%31,6250%Unchanged
On HLDG AG$1.7M0.5%50,1500%Unchanged
BSX Boston Scientific Corporation$1.7M0.5%26,6670%Unchanged
Spotify Technology S A$1.3M0.4%2,7150%Unchanged
Newamsterdam Pharma Co NV$823K0.2%25,7210%Unchanged
EWTX Edgewise Therapeutics Inc.$709K0.2%17,4600%Unchanged
CGON CG Oncology Inc.$561K0.2%8,2890%Unchanged
Esperion Therapeutics Inc Ne$502K0.1%183,0470%Unchanged
MLYS Mineralys Therapeutics Inc.$463K0.1%17,0810%Unchanged
FENC Fennec Pharmaceuticals Inc.$327K0.1%53,2340%Unchanged
IRON Disc Medicine Inc.$327K0.1%5,1150%Unchanged
VRDN Viridian Therapeutics Inc.$139K0.0%7,1260%Unchanged
FCX Freeport-McMoRan Inc.$133K0.0%2,2580%Unchanged
ACHR Archer Aviation Inc.$111K0.0%21,5340%Unchanged
AQST Aquestive Therapeutics Inc.$11K0.0%2,7200%Unchanged

Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $344M in share positions; options and bonds count in the 13F value but not here.

Biggest buys in Q2 2026

None this quarter.

Biggest sells in Q2 2026

None this quarter.

The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 0 new, 0 added, 0 trimmed, 0 sold out.

Sector mix

13F value by quarter

Q2 '25
Q3 '25
Q1 '26
Q2 '26
Reported 13F value: Q2 2025 $464M, Q3 2025 $379M, Q1 2026 $344M, Q2 2026 $344M.

Questions about Eleva Capital SAS

What does Eleva Capital SAS own?
In its Form 13F for Q2 2026, Eleva Capital SAS reported 24 holdings worth $344M. The five largest were CRH PLC Ord, Amer Sports Inc, NVDA, NFLX, GOOGL.
What did Eleva Capital SAS buy and sell in Q2 2026?
Eleva Capital SAS opened 0 new positions, added to 0, trimmed 0 and sold out of 0 compared with the quarter before.
When did Eleva Capital SAS file its latest 13F?
Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed July 2, 2026.

From Form 13F filed by Eleva Capital SAS (SEC CIK 0002054496) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds · Get this as JSON